Literature DB >> 22013922

Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure.

P Milberg1, M Fink, C Pott, G Frommeyer, J Biertz, N Osada, J Stypmann, G Mönnig, M Koopmann, G Breithardt, L Eckardt.   

Abstract

BACKGROUND AND PURPOSE Chronic heart failure (CHF) is associated with action potential prolongation and Ca(2+) overload, increasing risk of ventricular tachyarrhythmias (VT). We therefore investigated whether I(Ca) blockade was anti-arrhythmic in an intact perfused heart model of CHF. EXPERIMENTAL APPROACH CHF was induced in rabbits after 4 weeks of rapid ventricular pacing. Hearts from CHF and sham-operated rabbits were isolated and perfused (Langendorff preparation), with ablation of the AV node. VT was induced by erythromycin and low [K(+) ] (1.5mM). Electrophysiology of cardiac myocytes, with block of cation currents, was simulated by a mathematical model. KEY RESULTS Repolarization was prolonged in CHF hearts compared with sham-operated hearts. Action potential duration (APD) and overall dispersion of repolarization were further increased by erythromycin (300 µM) to block I(Kr) in CHF hearts. After lowering [K(+) ] to 1.5mM, CHF and sham hearts showed spontaneous episodes of polymorphic non-sustained VT. Additional infusion of verapamil (0.75 µM) suppressed early afterdepolarizations (EAD) and VT in 75% of sham and CHF hearts. Verapamil shortened APD and dispersion of repolarization, mainly by reducing transmural dispersion of repolarization via shortening of endocardial action potentials. Mathematical simulations showed that EADs were more effectively reduced by verapamil assuming a state-dependent block than a simple block of I(Ca) . CONCLUSIONS AND IMPLICATIONS Blockade of I(Ca) was highly effective in suppressing VT via reduction of transmural dispersion of repolarization and suppression of EAD. Such blockade might represent a novel therapeutic option to reduce risk of VT in structurally normal hearts and also in heart failure. LINKED ARTICLE This article is commented on by Stams et al., pp. 554-556 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476-5381.2011.01818.x.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22013922      PMCID: PMC3417488          DOI: 10.1111/j.1476-5381.2011.01721.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.

Authors:  L M Hondeghem; L Carlsson; G Duker
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

Review 2.  Cardiac ion channels.

Authors:  Dan M Roden; Jeffrey R Balser; Alfred L George; Mark E Anderson
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

Review 3.  Sudden death in heart failure associated with reduced left ventricular function: substrates, mechanisms, and evidence-based management, Part I.

Authors:  M O Sweeney
Journal:  Pacing Clin Electrophysiol       Date:  2001-05       Impact factor: 1.976

4.  Calcium channel heterogeneity in canine left ventricular myocytes.

Authors:  Hong-Sheng Wang; Ira S Cohen
Journal:  J Physiol       Date:  2003-01-31       Impact factor: 5.182

5.  Doppler echocardiography and tissue Doppler imaging in the healthy rabbit: differences of cardiac function during awake and anaesthetised examination.

Authors:  Jörg Stypmann; Markus A Engelen; Anne-Kristin Breithardt; Peter Milberg; Markus Rothenburger; Ole A Breithardt; Günter Breithardt; Lars Eckardt; Poulsen Nautrup Cordula
Journal:  Int J Cardiol       Date:  2006-06-27       Impact factor: 4.164

Review 6.  Arrhythmias in heart failure: current concepts of mechanisms and therapy.

Authors:  L Eckardt; W Haverkamp; R Johna; D Böcker; M C Deng; G Breithardt; M Borggrefe
Journal:  J Cardiovasc Electrophysiol       Date:  2000-01

7.  Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Authors:  Peter Milberg; Lars Eckardt; Hans-Jürgen Bruns; Julia Biertz; Shahram Ramtin; Nico Reinsch; Dirk Fleischer; Paulus Kirchhof; Larissa Fabritz; Günter Breithardt; Wilhelm Haverkamp
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

8.  A patient with LQTS in whom verapamil administration and permanent pacemaker implantation were useful for preventing torsade de pointes.

Authors:  Norihiro Komiya; Kyoei Tanaka; Yoshiyuki Doi; Satoki Fukae; Kojiro Nakao; Shojiro Isomoto; Shinji Seto; Katsusuke Yano
Journal:  Pacing Clin Electrophysiol       Date:  2004-01       Impact factor: 1.976

Review 9.  Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.

Authors:  Isabelle Mahé; Olivier Chassany; Anne-Sophie Grenard; Charles Caulin; Jean-François Bergmann
Journal:  Am J Cardiovasc Drugs       Date:  2003       Impact factor: 3.571

10.  Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure.

Authors:  Fadi G Akar; David S Rosenbaum
Journal:  Circ Res       Date:  2003-08-21       Impact factor: 17.367

View more
  14 in total

Review 1.  The physiology of cardiac calcium handling.

Authors:  Nils Bögeholz; Adam Muszynski; Christian Pott
Journal:  Wien Med Wochenschr       Date:  2012-06-16

2.  Verapamil as an antiarrhythmic agent in congestive heart failure: hopping from rabbit to human?

Authors:  Thom R G Stams; Vincent J A Bourgonje; Marc A Vos; Marcel A G van der Heyden
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

Review 4.  Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.

Authors:  Gerrit Frommeyer; Lars Eckardt
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

Review 5.  Calcium handling and ventricular tachyarrhythmias.

Authors:  Gerrit Frommeyer; Lars Eckardt; Peter Milberg
Journal:  Wien Med Wochenschr       Date:  2012-06-07

6.  Barbaloin inhibits ventricular arrhythmias in rabbits by modulating voltage-gated ion channels.

Authors:  Zhen-Zhen Cao; You-Jia Tian; Jie Hao; Pei-Hua Zhang; Zhi-Pei Liu; Wan-Zhen Jiang; Meng-Liu Zeng; Pei-Pei Zhang; Ji-Hua Ma
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

7.  Effects of wenxin keli on the action potential and L-type calcium current in rats with transverse aortic constriction-induced heart failure.

Authors:  Yu Chen; Yang Li; Lili Guo; Wen Chen; Mingjing Zhao; Yonghong Gao; Aiming Wu; Lixia Lou; Jie Wang; Xiaoqiu Liu; Yanwei Xing
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-11       Impact factor: 2.629

8.  Role of sarcoplasmic reticulum calcium in development of secondary calcium rise and early afterdepolarizations in long QT syndrome rabbit model.

Authors:  Po-Cheng Chang; Hung-Ta Wo; Hui-Ling Lee; Shien-Fong Lin; Ming-Shien Wen; Yen Chu; San-Jou Yeh; Chung-Chuan Chou
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 9.  Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction.

Authors:  Ramón Rodrigo; Matías Libuy; Felipe Feliú; Daniel Hasson
Journal:  Biomed Res Int       Date:  2013-07-14       Impact factor: 3.411

10.  Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator.

Authors:  Beth McMillan; David J Gavaghan; Gary R Mirams
Journal:  Toxicol Res (Camb)       Date:  2017-09-14       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.